Clorofil: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Clorofil
Largest movements
- Receivables within one year -€47,387
down €47,387 (-62.5%), from €75,816 to €28,429
of which Trade receivables: -€46,694
- Cash -€2,726
down €2,726 (-70.2%), from €3,880 to €1,154
mainly Trade debts (-€39,185) and Other debts (-€16,983)
- Deferred charges and accrued income -€2,376
down €2,376 (-84.2%), from €2,824 to €448
- Trade debts -€39,185
down €39,185 (-62.2%), from €62,977 to €23,792
- Other debts -€16,983
down €16,983 (-67.9%), from €25,000 to €8,017
- Profit (loss) carried forward +€3,881
up €3,881 (+55.1%), from -€7,044 to -€3,163
- Gross operating margin +€50,464
up €50,464 (+128.8%), from €39,192 to €89,656
- Staff costs +€41,672
up €41,672 (+95.9%), from €43,441 to €85,113
- Depreciation -€2,239
down €2,239 (-80.5%), from €2,781 to €541
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €85,137 | €32,107 | -€53,031 | -62.3% |
| Fixed assets | 21/28 | €2,617 | €2,075 | -€541 | -20.7% |
| Tangible fixed assets | 22/27 | €2,617 | €2,075 | -€541 | -20.7% |
| Plant, machinery and equipment | 23 | €2,617 | €2,075 | -€541 | -20.7% |
| Current assets | 29/58 | €82,520 | €30,031 | -€52,489 | -63.6% |
| Amounts receivable within one year | 40/41 | €75,816 | €28,429 | -€47,387 | -62.5% |
| Trade receivables | 40 | €75,123 | €28,429 | -€46,694 | -62.2% |
| Other amounts receivable | 41 | €693 | - | -€693 | |
| Cash at bank and in hand | 54/58 | €3,880 | €1,154 | -€2,726 | -70.2% |
| Deferred charges and accrued income | 490/1 | €2,824 | €448 | -€2,376 | -84.2% |
| Total equity and liabilities | 10/49 | €85,137 | €32,107 | -€53,031 | -62.3% |
| Equity | 10/15 | -€5,044 | -€1,163 | +€3,881 | +76.9% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€7,044 | -€3,163 | +€3,881 | +55.1% |
| Amounts payable | 17/49 | €90,181 | €33,269 | -€56,912 | -63.1% |
| Amounts payable within one year | 42/48 | €90,181 | €33,269 | -€56,912 | -63.1% |
| Trade debts | 44 | €62,977 | €23,792 | -€39,185 | -62.2% |
| Suppliers | 440/4 | €62,977 | €23,792 | -€39,185 | -62.2% |
| Taxes, remuneration and social security | 45 | €2,204 | €1,460 | -€744 | -33.7% |
| Taxes | 450/3 | €70 | €296 | +€225 | +319.7% |
| Remuneration and social security | 454/9 | €2,133 | €1,164 | -€969 | -45.4% |
| Other amounts payable | 47/48 | €25,000 | €8,017 | -€16,983 | -67.9% |
| Remuneration, social security and pensions | 62 | €43,441 | €85,113 | +€41,672 | +95.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,781 | €541 | -€2,239 | -80.5% |
| Gross operating margin | 9900 | €39,192 | €89,656 | +€50,464 | +128.8% |
| Operating profit (loss) | 9901 | -€7,030 | €4,002 | +€11,032 | |
| Financial charges | 65/66B | €14 | €120 | +€107 | +789.1% |
| Recurring financial charges | 65 | €14 | €120 | +€107 | +789.1% |
| Profit (loss) for the period before taxes | 9903 | -€7,044 | €3,881 | +€10,925 | |
| Profit (loss) for the period | 9904 | -€7,044 | €3,881 | +€10,925 | |
| Profit (loss) for the period to be appropriated | 9905 | -€7,044 | €3,881 | +€10,925 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.